Wird geladen...
Delafloxacin: First Global Approval
Delafloxacin (Baxdela™) is a fluoroquinolone antibacterial with activity against both gram-positive and gram-negative pathogens being developed by Melinta Therapeutics. The drug is being investigated or considered as a treatment for various bacterial infections and in June 2017 received approval in...
Gespeichert in:
| Veröffentlicht in: | Drugs |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer International Publishing
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6208769/ https://ncbi.nlm.nih.gov/pubmed/28748399 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-017-0790-5 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|